The San Diego-based company began rolling out the system in Spain, Belgium and Poland. It plans for a launch next week in the Netherlands, too. In some countries, the system replaces the previous-generation Dexcom One sensor.
ONE+ uses Dexcom’s established sensor design, with the company incorporating feedback from users and healthcare professionals to build it. The company said this ensured an easy-to-use, highly effective CGM experience for people treating type 1 or type 2 diabetes with insulin.
This version of the platform utilizes the latest-generation G7 sensor, while the previous version used the G6. CEO Kevin Sayer told Drug Delivery Business News last month that he expected to complete this transfer during the first quarter of 2024.